Insiders Johnson & Johnson Börse Stuttgart

Equities

Market Closed - Börse Stuttgart Other stock markets 10:45:20 26/06/2024 pm IST			5-day change	1st Jan Change
137.3 ^EUR	-0.04%		+1.27%	-2.90%

24/06	US Supreme Court gives pharma companies a chance to thwart terrorism-funding lawsuit	RE
24/06	J&J: 50M pupils helped through 'Sight for Kids' program	CF

Valneva Names New Chief Scientific Officer	21/05	MT
Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer	17/04	MT
Clearside Biomedical Names Victor Chong Chief Medical Officer	18/03	MT
Johnson & Johnson Insider Sold Shares Worth $1,441,765, According to a Recent SEC Filing	14/03	MT
LivaNova Names Vladimir Makatsaria as Chief Executive	05/02	MT
Joseph Wolk, CFO of J&J: End of patent for its flagship drug	23/01	MT
Johnson & Johnson Names Eugene Woods as Board Member	01/12	DJ
Johnson & Johnson Appoints Eugene A. Woods to its Board of Directors	01/12	CI
Johnson & Johnson Announces Executive Changes	24/23/24	CI
Biomea Fusion Names Juan Pablo Frias as Chief Medical Officer, Steve Morris to Become Chief Development Officer	31/23/31	MT
Top Stories at Midday: Yellow Calls it Quits; JNJ Unit Loses Second Bid at Bankruptcy; JB Hunt Buys Nikola Trucks, Walmart Raises Flipkart Stake	31/23/31	MT
Insider Sell: Johnson & Johnson	28/23/28	MT
Insider Sell: Johnson & Johnson	28/23/28	MT
INTERVIEW - Joseph Wolk, Johnson & Johnson: inflation law may hamper innovation	20/23/20	MT
Idorsia's Commercial Chief to Step Down	30/23/30	MT
Nyxoah Appoints Chief Commercial Officer	11/23/11	MT
Johnson & Johnson Announces the Retirement of Ian E. L. Davis as Director	03/23/03	CI
STAAR Surgical Appoints Warren Foust as Chief Operating Officer	29/23/29	MT
Insider Sell: Johnson & Johnson	09/23/09	MT
Johnson & Johnson Names Paula A. Johnson, President of Wellesley College, to Its Board of Directors	15/23/15	CI

No results for this search

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 11:00 pm IST